Clearmind Medicine (NASDAQ:CMND) Posts Quarterly Earnings Results

Clearmind Medicine (NASDAQ:CMND) released its quarterly earnings data on Wednesday. The company reported ($0.11) earnings per share for the quarter, Zacks reports.

Clearmind Medicine Trading Down 0.3 %

CMND traded down $0.01 during trading on Friday, reaching $1.49. 10,014 shares of the company traded hands, compared to its average volume of 233,126. Clearmind Medicine has a 12-month low of $0.95 and a 12-month high of $2.30. The firm has a fifty day simple moving average of $1.40 and a 200 day simple moving average of $1.41. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.01.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.